Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Oncology
Join Editorial Board Propose a Special Issue
Print ISSN: 1019-6439 Online ISSN: 1791-2423
Journal Cover
January-2018 Volume 52 Issue 1

Full Size Image

Cover Legend PDF

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
January-2018 Volume 52 Issue 1

Full Size Image

Cover Legend PDF

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

The STAT-ROS cycle extends IFN‑induced cancer cell apoptosis

  • Authors:
    • Yan Wang
    • Xiaoyu Yu
    • Hongtao Song
    • Di Feng
    • Yang Jiang
    • Shuang Wu
    • Jingshu Geng
  • View Affiliations / Copyright

    Affiliations: Department of Pathology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150081, P.R. China
  • Pages: 305-313
    |
    Published online on: November 8, 2017
       https://doi.org/10.3892/ijo.2017.4196
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

In mammals, the signal transducer and activator of transcription (STAT) protein processes mitochondria importation targets and mitochondria respiratory complexes, and triggers reactive oxygen species (ROS) generation, which conversely rapidly initiates the activation of STAT. Interferon (IFN) administration increases cancer cell apoptosis via STAT activation and ROS accumulation. However, the existence of a STAT-ROS cycle and how it affects IFN‑induced cancer cellular apoptosis are unclear. In the present study, we used MCF7 breast cancer cells and confirmed that a combination of IFN‑α/β/γ incubation induced STAT1/3 phosphorylation and mitochondria importation, which increased mitochondria respiratory complexes, the cellular oxygen consumption rate (OCR), and ROS production, followed by cellular apoptosis. We also found that STAT1/3 overexpression induced mitochondria respiratory complexes and ROS production. Additionally, ROS induced by H2O2 induced phosphorylation of STAT1/3 and promoted mitochondria importation. STAT1/3 deletion suppressed H2O2-induced acute cellular OCR, increasing the ROS level and indicating that STAT1/3 is necessary for ROS-induced mitochondria OCR and further ROS production, suggesting the existence of a STAT-ROS cycle. We next found that IFN induced mitochondria respiratory complexes followed by induction of OCR, ROS, and apoptosis, which were partially blocked by STAT1/3 deletion. Additionally, the suppression of ROS inhibited IFN‑induced STAT1/3 activation. Finally, we discovered that this cycle exists also in A431 and HeLa cancer cells. These results indicate that a STAT-ROS cycle extends IFN‑induced cellular apoptosis.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Arbuthnot P, Capovilla A and Kew M: Putative role of hepatitis B virus X protein in hepatocarcinogenesis: Effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK/STAT pathways. J Gastroenterol Hepatol. 15:357–368. 2000. View Article : Google Scholar : PubMed/NCBI

2 

Beebe K, Lee WC and Micchelli CA: JAK/STAT signaling coordinates stem cell proliferation and multilineage differentiation in the Drosophila intestinal stem cell lineage. Dev Biol. 338:28–37. 2010. View Article : Google Scholar

3 

Steelman LS, Pohnert SC, Shelton JG, Franklin RA, Bertrand FE and McCubrey JA: JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis. Leukemia. 18:189–218. 2004. View Article : Google Scholar : PubMed/NCBI

4 

Aaronson DS and Horvath CM: A road map for those who don't know JAK-STAT. Science. 296:1653–1655. 2002. View Article : Google Scholar : PubMed/NCBI

5 

Schindler C and Darnell JE Jr: Transcriptional responses to polypeptide ligands: The JAK-STAT pathway. Annu Rev Biochem. 64:621–651. 1995. View Article : Google Scholar : PubMed/NCBI

6 

Yuan ZL, Guan YJ, Chatterjee D and Chin YE: Stat3 dimerization regulated by reversible acetylation of a single lysine residue. Science. 307:269–273. 2005. View Article : Google Scholar : PubMed/NCBI

7 

Xie Y, Kole S, Precht P, Pazin MJ and Bernier M: S-glutathionylation impairs signal transducer and activator of transcription 3 activation and signaling. Endocrinology. 150:1122–1131. 2009. View Article : Google Scholar :

8 

Ray S, Boldogh I and Brasier AR: STAT3 NH2-terminal acetylation is activated by the hepatic acute-phase response and required for IL-6 induction of angiotensinogen. Gastroenterology. 129:1616–1632. 2005. View Article : Google Scholar : PubMed/NCBI

9 

Horvath CM: The Jak-STAT pathway stimulated by interleukin 6. Sci STKE. 2004:tr92004.PubMed/NCBI

10 

Leonard WJ: Role of Jak kinases and STATs in cytokine signal transduction. Int J Hematol. 73:271–277. 2001. View Article : Google Scholar : PubMed/NCBI

11 

Levy JB, Schindler C, Raz R, Levy DE, Baron R and Horowitz MC: Activation of the JAK-STAT signal transduction pathway by oncostatin-M cultured human and mouse osteoblastic cells. Endocrinology. 137:1159–1165. 1996. View Article : Google Scholar : PubMed/NCBI

12 

Lufei C, Ma J, Huang G, Zhang T, Novotny-Diermayr V, Ong CT and Cao X: GRIM-19, a death-regulatory gene product, suppresses Stat3 activity via functional interaction. EMBO J. 22:1325–1335. 2003. View Article : Google Scholar : PubMed/NCBI

13 

Tamminen P, Anugula C, Mohammed F, Anjaneyulu M, Larner AC and Sepuri NB: The import of the transcription factor STAT3 into mitochondria depends on GRIM-19, a component of the electron transport chain. J Biol Chem. 288:4723–4732. 2013. View Article : Google Scholar

14 

Lee HJ, Oh YK, Rhee M, Lim JY, Hwang JY, Park YS, Kwon Y, Choi KH, Jo I, Park SI, et al: The role of STAT1/IRF-1 on synergistic ROS production and loss of mitochondrial transmembrane potential during hepatic cell death induced by LPS/d-GalN. J Mol Biol. 369:967–984. 2007. View Article : Google Scholar : PubMed/NCBI

15 

Wegrzyn J, Potla R, Chwae YJ, Sepuri NB, Zhang Q, Koeck T, Derecka M, Szczepanek K, Szelag M, Gornicka A, et al: Function of mitochondrial Stat3 in cellular respiration. Science. 323:793–797. 2009. View Article : Google Scholar : PubMed/NCBI

16 

Chen Q, Vazquez EJ, Moghaddas S, Hoppel CL and Lesnefsky EJ: Production of reactive oxygen species by mitochondria: Central role of complex III. J Biol Chem. 278:36027–36031. 2003. View Article : Google Scholar : PubMed/NCBI

17 

Batandier C, Guigas B, Detaille D, El-Mir MY, Fontaine E, Rigoulet M and Leverve XM: The ROS production induced by a reverse-electron flux at respiratory-chain complex 1 is hampered by metformin. J Bioenerg Biomembr. 38:33–42. 2006. View Article : Google Scholar : PubMed/NCBI

18 

Kim HS, Cho IH, Kim JE, Shin YJ, Jeon JH, Kim Y, Yang YM, Lee KH, Lee JW, Lee WJ, et al: Ethyl pyruvate has an anti-inflammatory effect by inhibiting ROS-dependent STAT signaling in activated microglia. Free Radic Biol Med. 45:950–963. 2008. View Article : Google Scholar : PubMed/NCBI

19 

Liu T, Castro S, Brasier AR, Jamaluddin M, Garofalo RP and Casola A: Reactive oxygen species mediate virus-induced STAT activation: Role of tyrosine phosphatases. J Biol Chem. 279:2461–2469. 2004. View Article : Google Scholar

20 

Simon AR, Rai U, Fanburg BL and Cochran BH: Activation of the JAK-STAT pathway by reactive oxygen species. Am J Physiol. 275:C1640–C1652. 1998. View Article : Google Scholar : PubMed/NCBI

21 

Parkin J and Cohen B: An overview of the immune system. Lancet. 357:1777–1789. 2001. View Article : Google Scholar : PubMed/NCBI

22 

Kiladjian JJ, Giraudier S and Cassinat B: Interferon-alpha for the therapy of myeloproliferative neoplasms: Targeting the malignant clone. Leukemia. 30:776–781. 2016. View Article : Google Scholar

23 

Cao ZH, Zheng QY, Li GQ, Hu XB, Feng SL, Xu GL and Zhang KQ: STAT1-mediated down-regulation of Bcl-2 expression is involved in IFN-γ/TNF-α-induced apoptosis in NIT-1 cells. PLoS One. 10:e01209212015. View Article : Google Scholar

24 

Ethiraj P, Veerappan K, Samuel S and Sivapatham S: Inhibitory effects of interferon-β on hepatocellular carcinoma HepG2 via Akt/STAT phosphorylation. Fundam Clin Pharmacol. 29:278–285. 2015. View Article : Google Scholar : PubMed/NCBI

25 

Bello C, Vazquez-Blomquist D, Miranda J, Garcia Y, Novoa LI, Palenzuela D and Bello I: Regulation by IFN-α/IFN-γ co-formulation (HerberPAG®) of genes involved in interferon-STAT-pathways and apoptosis in U87MG. Curr Top Med Chem. 14:351–358. 2014. View Article : Google Scholar

26 

Zídek Z, Jansa P and Kmoníčková E: Activation of respiratory complex II by interferon-gamma and its inhibition by pyrimidine derivatives. Neuro Endocrinol Lett. 35(Suppl 2): 141–148. 2014.

27 

Huang G, Chen Y, Lu H and Cao X: Coupling mitochondrial respiratory chain to cell death: An essential role of mitochondrial complex I in the interferon-beta and retinoic acid-induced cancer cell death. Cell Death Differ. 14:327–337. 2007. View Article : Google Scholar

28 

Kim KB, Eton O, East MJ, Hodges C, Papadopoulos NE, Grimm EA and Bedikian AY: Pilot study of high-dose, concurrent biochemotherapy for advanced melanoma. Cancer. 101:596–603. 2004. View Article : Google Scholar : PubMed/NCBI

29 

Henry SC, Schmidt EA, Fessler MB and Taylor GA: Palmitoylation of the immunity related GTPase, Irgm1: Impact on membrane localization and ability to promote mitochondrial fission. PLoS One. 9:e950212014. View Article : Google Scholar : PubMed/NCBI

30 

Yang JY, Deng W, Chen Y, Fan W, Baldwin KM, Jope RS, Wallace DC and Wang PH: Impaired translocation and activation of mitochondrial Akt1 mitigated mitochondrial oxidative phosphorylation Complex V activity in diabetic myocardium. J Mol Cell Cardiol. 59:167–175. 2013. View Article : Google Scholar : PubMed/NCBI

31 

Tian Z, Miyata K, Kadomatsu T, Horiguchi H, Fukushima H, Tohyama S, Ujihara Y, Okumura T, Yamaguchi S, Zhao J, et al: ANGPTL2 activity in cardiac pathologies accelerates heart failure by perturbing cardiac function and energy metabolism. Nat Commun. 7:130162016. View Article : Google Scholar : PubMed/NCBI

32 

Sansbury BE, Riggs DW, Brainard RE, Salabei JK, Jones SP and Hill BG: Responses of hypertrophied myocytes to reactive species: Implications for glycolysis and electrophile metabolism. Biochem J. 435:519–528. 2011. View Article : Google Scholar : PubMed/NCBI

33 

Zorov DB, Juhaszova M and Sollott SJ: Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev. 94:909–950. 2014. View Article : Google Scholar : PubMed/NCBI

34 

Chin YE, Kitagawa M, Kuida K, Flavell RA and Fu XY: Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol Cell Biol. 17:5328–5337. 1997. View Article : Google Scholar : PubMed/NCBI

35 

Smith CC, Dixon RA, Wynne AM, Theodorou L, Ong SG, Subrayan S, Davidson SM, Hausenloy DJ and Yellon DM: Leptin-induced cardioprotection involves JAK/STAT signaling that may be linked to the mitochondrial permeability transition pore. Am J Physiol Heart Circ Physiol. 299:H1265–H1270. 2010. View Article : Google Scholar : PubMed/NCBI

36 

Lemoine S, Zhu L, Legallois D, Massetti M, Manrique A and Hanouz JL: Atorvastatin-induced cardioprotection of human myocardium is mediated by the inhibition of mitochondrial permeability transition pore opening via tumor necrosis factor-α and Janus kinase/signal transducers and activators of transcription pathway. Anesthesiology. 118:1373–1384. 2013. View Article : Google Scholar : PubMed/NCBI

37 

Dvorak K and Dvorak B: Role of interleukin-6 in Barrett's esophagus pathogenesis. World J Gastroenterol. 19:2307–2312. 2013. View Article : Google Scholar : PubMed/NCBI

38 

Santambrogio P, Erba BG, Campanella A, Cozzi A, Causarano V, Cremonesi L, Gallì A, Della Porta MG, Invernizzi R and Levi S: Over-expression of mitochondrial ferritin affects the JAK2/STAT5 pathway in K562 cells and causes mitochondrial iron accumulation. Haematologica. 96:1424–1432. 2011. View Article : Google Scholar : PubMed/NCBI

39 

Park SJ1, Lee JH, Kim HY, Choi YH, Park JS, Suh YH, Park SM, Joe EH and Jou I: Astrocytes, but not microglia, rapidly sense H2O2 via STAT6 phosphorylation, resulting in cyclooxygenase-2 expression and prostaglandin release. J Immunol. 188:5132–5141. 2012. View Article : Google Scholar : PubMed/NCBI

40 

Jesel M, Isch-Treussard C, Poenaru S and Isch F: Electromyography in the study of thyrotoxic myopathies. Rev Electroencephalogr Neurophysiol Clin. 3:183–192. 1973.In French. View Article : Google Scholar : PubMed/NCBI

41 

Sartor CI, Dziubinski ML, Yu CL, Jove R and Ethier SP: Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells. Cancer Res. 57:978–987. 1997.PubMed/NCBI

42 

Sahu RP and Srivastava SK: The role of STAT-3 in the induction of apoptosis in pancreatic cancer cells by benzyl isothiocyanate. J Natl Cancer Inst. 101:176–193. 2009. View Article : Google Scholar : PubMed/NCBI

43 

Thoennissen NH, Iwanski GB, Doan NB, Okamoto R, Lin P, Abbassi S, Song JH, Yin D, Toh M, Xie WD, et al: Cucurbitacin B induces apoptosis by inhibition of the JAK/STAT pathway and potentiates antiproliferative effects of gemcitabine on pancreatic cancer cells. Cancer Res. 69:5876–5884. 2009. View Article : Google Scholar : PubMed/NCBI

44 

Liby K, Voong N, Williams CR, Risingsong R, Royce DB, Honda T, Gribble GW, Sporn MB and Letterio JJ: The synthetic triterpenoid CDDO-Imidazolide suppresses STAT phosphorylation and induces apoptosis in myeloma and lung cancer cells. Clin Cancer Res. 12:4288–4293. 2006. View Article : Google Scholar : PubMed/NCBI

45 

Mora LB, Buettner R, Seigne J, Diaz J, Ahmad N, Garcia R, Bowman T, Falcone R, Fairclough R, Cantor A, et al: Constitutive activation of Stat3 in human prostate tumors and cell lines: Direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells. Cancer Res. 62:6659–6666. 2002.PubMed/NCBI

46 

Ni Z, Lou W, Leman ES and Gao AC: Inhibition of constitutively activated Stat3 signaling pathway suppresses growth of prostate cancer cells. Cancer Res. 60:1225–1228. 2000.PubMed/NCBI

47 

Burke WM, Jin X, Lin HJ, Huang M, Liu R, Reynolds RK and Lin J: Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells. Oncogene. 20:7925–7934. 2001. View Article : Google Scholar : PubMed/NCBI

48 

Bromberg J: Stat proteins and oncogenesis. J Clin Invest. 109:1139–1142. 2002. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Wang Y, Yu X, Song H, Feng D, Jiang Y, Wu S and Geng J: The STAT-ROS cycle extends IFN‑induced cancer cell apoptosis. Int J Oncol 52: 305-313, 2018.
APA
Wang, Y., Yu, X., Song, H., Feng, D., Jiang, Y., Wu, S., & Geng, J. (2018). The STAT-ROS cycle extends IFN‑induced cancer cell apoptosis. International Journal of Oncology, 52, 305-313. https://doi.org/10.3892/ijo.2017.4196
MLA
Wang, Y., Yu, X., Song, H., Feng, D., Jiang, Y., Wu, S., Geng, J."The STAT-ROS cycle extends IFN‑induced cancer cell apoptosis". International Journal of Oncology 52.1 (2018): 305-313.
Chicago
Wang, Y., Yu, X., Song, H., Feng, D., Jiang, Y., Wu, S., Geng, J."The STAT-ROS cycle extends IFN‑induced cancer cell apoptosis". International Journal of Oncology 52, no. 1 (2018): 305-313. https://doi.org/10.3892/ijo.2017.4196
Copy and paste a formatted citation
x
Spandidos Publications style
Wang Y, Yu X, Song H, Feng D, Jiang Y, Wu S and Geng J: The STAT-ROS cycle extends IFN‑induced cancer cell apoptosis. Int J Oncol 52: 305-313, 2018.
APA
Wang, Y., Yu, X., Song, H., Feng, D., Jiang, Y., Wu, S., & Geng, J. (2018). The STAT-ROS cycle extends IFN‑induced cancer cell apoptosis. International Journal of Oncology, 52, 305-313. https://doi.org/10.3892/ijo.2017.4196
MLA
Wang, Y., Yu, X., Song, H., Feng, D., Jiang, Y., Wu, S., Geng, J."The STAT-ROS cycle extends IFN‑induced cancer cell apoptosis". International Journal of Oncology 52.1 (2018): 305-313.
Chicago
Wang, Y., Yu, X., Song, H., Feng, D., Jiang, Y., Wu, S., Geng, J."The STAT-ROS cycle extends IFN‑induced cancer cell apoptosis". International Journal of Oncology 52, no. 1 (2018): 305-313. https://doi.org/10.3892/ijo.2017.4196
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team